Epidemiology of pancreatic cancer in Norway: Trends in incidence, basis of diagnosis and survival 1965-2007

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 1, 2010, Pages 82-92

  Søreide, Kjetil ^a,b   Aagnes, Bjarte ^c   Møller, Bjørn ^c   Westgaard, Arne ^d   Bray, Freddie ^c,e  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Department of Etiological Research ^*  (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Diagnosis; Epidemiology; Incidence; Mortality; Pancreatic cancer; Registry; Survival; Treatment

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOSCOPY; FEMALE; HISTOLOGY; HUMAN; MALE; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORWAY; PANCREATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE;

EID: 73649131231     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903358899     Document Type: Article

References (60)

1. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology 2009;136:1134-1144
2. Luo J, Adami HO, Reilly M, Ekbom A, Nordenvall C, Ye W. Interpreting trends of pancreatic cancer incidence and mortality: a nation-wide study in Sweden (1960-2003). Cancer Causes Control 2008;19:89-96.
3. Katanoda K, Dongmei Q. Comparison of time trends in pancreatic cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IVVIII. Jpn J Clin Oncol 2008;38:165-166 (Pubitemid 351337964)
4. Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 2008;10:58-62.
5. Zhang J, Dhakal I, Yan H, Phillips M, Kesteloot H. Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973-2002. Ann Oncol 2007;18:1268-1279
6. Nagenthiraja K, Ewertz M, Engholm G, Storm HH. Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000. Acta Oncol 2007;46:1064-1069
7. Fitzsimmons D, Osmond C, George S, Johnson CD. Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000. Br J Surg 2007;94:1162-1171
8. Ferlay J, Bray F, Pisani P, Parkin DMGLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC Press; 2004.
9. Tumours of the exocrine pancreas. In: Hamilton SR, Aaltonen LA, editors. Pathology and Genetics. Tumours of the Digestive System (WHO Classification of Tumours, Volume2, Third Edition). Lyon, France: IARC Press; 2000. p. 220-251
10. Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 2006;24:87-94.
11. Hruban RH, Maitra A, Goggins M. Update on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol 2008;1: 306-316
12. Buchler MW, Kleeff J, Friess H. Surgical treatment of pancreatic cancer. J Am Coll Surg 2007;205(4 Suppl):S81-6.
13. Ko AH, Tempero MA. Personalized medicine for pancreatic cancer: a step in the right direction. Gastroenterology 2009;136:43-45
14. Sharp L, Carsin AE, Cronin-Fenton DP, O'Driscoll D, Comber H. Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland. Eur J Cancer 2009 May;45(8):1450-1459
15. Brenner H, Hakulinen T. Maximizing the benefits of modelbased period analysis of cancer patient survival. Cancer Epidemiol Biomarkers Prev 2007;16:1675-1681 (Pubitemid 47294837)
16. Estève J, Benhamou E, Raymond LDescriptive epidemiology. In: Statistical methods in cancer research, Vol.IV. IARC Science Publications; Lyon, France. 1994. p. 128.
17. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51-64.
18. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933-942
19. Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004-2010
20. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002;360:1131-1135 (Pubitemid 35246487)
21. Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002;20:826-832 (Pubitemid 34111392)
22. Dickman PW, Coviello E, Hills M. Estimating and modelling relative survival. Stata J 2009;In press.
23. Teiblum S, Thygesen LC, Johansen C. Sixty-one years of pancreatic cancer in Denmark from 1943 to 2003: a nationwide study. Pancreas 2009;38:374-378
24. Wood HE, Gupta S, Kang JY, Quinn MJ, Maxwell JD, Mudan S, et al. Pancreatic cancer in England and Wales 1975-2000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther 2006;23:1205-1214
25. Gawron AJ, Gapstur SM, Fought AJ, Talamonti MS, Skinner HG. Sociodemographic and tumor characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol 2008;97:578-582
26. Shaib Y, Davila J, Naumann C, El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. population-based study. Am J Gastroenterol 2007;102:1377-1382
27. David M, Lepage C, Jouve JL, Jooste V, Chauvenet M, Faivre J, et al. Management and prognosis of pancreatic cancer over a 30-year period. Br J Cancer. 2009;101:215-218
28. Hartwig W, Schneider L, Diener MK, Bergmann F, Buchler MW, Werner J. Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg 2009;96:5-20.
29. Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, Kloppel G, et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005;54:385-387
30. Cancer Registry of Norway. Available at: www.kreftregis teret.no.
31. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009 May;45(7):1218-1231
32. Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 2005;114:992-995
33. Batty GD, Kivimaki M, Morrison D, Huxley R, Smith GD, Clarke R, et al. Risk factors for pancreatic cancer mortality: Extended Follow-up of the original Whitehall study. Cancer Epidemiol Biomarkers Prev 2009 Feb;18(2):673-675
34. Teich N. Pancreatic cancer: cause and result of diabetes mellitus. Gastroenterology 2008;134:344-345
35. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:197-209.
36. Larsson SC, Hakansson N, Giovannucci E, Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedishwomenand men. J Natl Cancer Inst 2006;98:407-413
37. Teras LR, Patel AV, Rodriguez C, Thun MJ, Calle EE. Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States). Cancer Causes Control 2005;16:1035-1040
38. Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst 2005;97:1458-1465
39. Ghadirian P, Lynch HT, Krewski D. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 2003;27:87-93.
40. Qiu D, Kurosawa M, Lin Y, Inaba Y, Matsuba T, Kikuchi S, et al. 2005;Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 15Suppl 2S157-67.
41. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am 1998;7:67-91.
42. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1998;90:1710-1719
43. Michaud DS, Liu S, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst 2002;94:1293-1300
44. Villeneuve PJ, Johnson KC, Hanley AJ, Mao Y. Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Canadian Cancer Registries Epidemiology Research Group. Eur J Cancer Prev 2000;9:49-58.
45. Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009;10:88-95.
46. Hart AR, Kennedy H, Harvey I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 2008;6:275-282
47. Petersen GM, de Andrade M, Goggins M, Hruban RH, Bondy M, Korczak JF, et al. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2006;15:704-710
48. Larghi A, Verna EC, Lecca PG, Costamagna G: Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin Cancer Res 2009;15:1907-1914
49. Mulder I, Hoogenveen RT, van Genugten ML, Lankisch PG, Lowenfels AB, de Hollander AE, et al. Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol 2002;14:1343-1353
50. Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 2005;128:1626-1641
51. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 2008;247:456-462
52. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006 Nov;10(9):1199-210; discussion 1210-1211
53. Rupp CC, Linehan DC. Extended lymphadenectomy in the surgery of pancreatic adenocarcinoma and its relation to quality improvement issues. J Surg Oncol 2009;99:207-214
54. Weitz J, Kienle P, Schmidt J, Friess H, Buchler MW. Portal vein resection for advanced pancreatic head cancer. J Am Coll Surg 2007;204:712-716
55. Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 2003;138:1316-1322
56. Hristov B, Reddy S, Lin MDS, Cameron JL, Pawlik TM, Hruban RH, et al. Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 2009 Apr 24. [Epub ahead of print], in press.
57. Michalski CW, Erkan M, Huser N, Muller MW, Hartel M, Friess H, et al. Resection of primary pancreatic cancer and liver metastasis: a systematic review. Dig Surg 2008;25: 473-480
58. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997;225(5):621-33; discussion 633-636
59. Søreide K, Immervoll H, Molven A. Precursors to pancreatic cancer. Tidsskr Nor Laegeforen 2006;126:905-908
60. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores- Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-987